Immunic AG | WebDisclosure

Basculer en Français

9803	Companies
196608	Keywords
127603	Articles
104520	Press releases

Home
Companies
Immunic AG

BRIEF

published on 02/04/2026 at 12:35, 5 hours 35 minutes ago

Immunic dévoile des résultats prometteurs pour son essai de phase 2 sur le vidofludimus calcique

Vidofludimus Calcium Essai De Phase 2 Sclérose En Plaques Progressive Forum ACTRIMS 2026 Effets Antiviraux
BRIEF

published on 02/04/2026 at 12:35, 5 hours 35 minutes ago

Immunic Unveils Promising Phase 2 Trial Results for Vidofludimus Calcium

Vidofludimus Calcium Phase 2 Trial Progressive Multiple Sclerosis ACTRIMS Forum 2026 Antiviral Effects
PRESS RELEASE

published on 02/04/2026 at 12:30, 5 hours 40 minutes ago

Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the ACTRIMS Forum 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis
Immunic to present additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the ACTRIMS Forum 2026, reinforcing potential in Progressive Multiple Sclerosis. Latest research findings to be shared at event

Immunic Vidofludimus Calcium Progressive Multiple Sclerosis Phase 2 CALLIPER Trial ACTRIMS Forum 2026
BRIEF

published on 01/07/2026 at 12:35, 28 days 5 hours ago

Bilan d'Immunic 2025 : progrès et perspectives d'avenir

Vidofludimus Calcium Neuroprotection Essais Cliniques Sur La Sclérose En Plaques Réalisations Immunitaires Étapes Clés De La Biotechnologie
BRIEF

published on 01/07/2026 at 12:35, 28 days 5 hours ago

Immunic Reviews 2025 Progress and Sets Sights on Future Goals

Vidofludimus Calcium Neuroprotection Multiple Sclerosis Trials Immunic Accomplishments Biotechnology Milestones
PRESS RELEASE

published on 01/07/2026 at 12:30, 28 days 5 hours ago

Immunic Highlights 2025 Accomplishments and Upcoming Milestones
Immunic Inc. highlights its 2025 accomplishments & upcoming milestones including phase 3 trials for Vidofludimus Calcium in relapsing Multiple Sclerosis, positive data in Progressive MS, & potential for IMU-856 in weight management

Immunic Inc. Multiple Sclerosis Vidofludimus Calcium IMU-856 2025 Accomplishments
BRIEF

published on 11/26/2025 at 12:35, 2 months 8 days ago

Immunic to Join Evercore ISI Healthcare Conference in December

Biotechnology Immunic Investor Meetings Healthcare Conference Neurologic Diseases
BRIEF

published on 11/26/2025 at 12:35, 2 months 8 days ago

Immunic participera à la conférence Evercore ISI Healthcare en décembre

Biotechnologie Conférence Sur Les Soins De Santé Immunitaire Maladies Neurologiques Réunions Avec Les Investisseurs
PRESS RELEASE

published on 11/26/2025 at 12:30, 2 months 8 days ago

Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December
Immunic to participate in the 8th Annual Evercore ISI Healthcare Conference in December. Dr. Daniel Vitt to speak at fireside chat on novel oral therapies for neurologic and gastrointestinal diseases

Gastrointestinal Diseases Immunic Neurologic Diseases Evercore ISI Healthcare Conference Daniel Vitt
BRIEF

published on 11/13/2025 at 12:35, 2 months 21 days ago

Immunic, Inc. Announces Third Quarter 2025 Financial Results and Updates

Financial Results Clinical Trials Immunic, Inc. Multiple Sclerosis Vidofludimus Calcium

Accesswire

Published on 02/04/2026 at 18:00, 10 minutes ago

Lithium South AGSM Update
Published on 02/04/2026 at 16:15, 1 hour 55 minutes ago

Trans Canada Gold Enters into an Option Agreement with Bear Mountain Gold Mines to Acquire a 60% Interest in the Harrison Lake District Scale Gold Property, with $10.0 Million Dollars in Prior Exploration Expenditures
Published on 02/04/2026 at 15:45, 2 hours 25 minutes ago

Patriot.Tv's Jd Rucker Explains Billie Eilish's Comments on ICE, Offers ICE Commentary as Exhibit A of Celebrity Sound Bite Politics
Published on 02/04/2026 at 15:00, 3 hours 10 minutes ago

Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale
Published on 02/04/2026 at 14:30, 3 hours 40 minutes ago

Datametrex Expands Business In Data Centres

View all ACCESSWIRE

EQS Group

Published on 02/04/2026 at 17:48, 21 minutes ago

FIGEAC AÉRO: Q3 & 9M 2025/26 REVENUE
Published on 02/04/2026 at 17:48, 21 minutes ago

FIGEAC AÉRO: CHIFFRE D’AFFAIRES T3 & 9M 2025/26
Published on 02/04/2026 at 17:45, 24 minutes ago

LIGHTON: Chiffre d'affaires annuel 2025 en hausse de 54%.
Published on 02/04/2026 at 17:45, 24 minutes ago

LIGHTON: FY 2025 Revenue up by 54%.
Published on 02/04/2026 at 17:45, 25 minutes ago

REALITES INFORME LE MARCHE DE L'AVANCEMENT DE LA PROCEDURE DE REDRESSEMENT JUDICIAIRE LA CONCERNANT AINSI QUE DE SON CALENDRIER PREVISIONNEL DE PUBLICATION DES COMPTES

Les Echos

Published on 02/04/2026 at 17:45, 25 minutes ago

Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 25 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 02/04/2026 at 17:45, 25 minutes ago

Janvier 2026
Published on 02/04/2026 at 17:45, 25 minutes ago

INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 02/04/2026 at 17:45, 25 minutes ago

Informations relatives au nombre total de droits de vote et d’actions 2026 01 31

View all LES ECHOS COMFI WIRE